logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
返回期刊详情
Journal of Medical Economics 封面图

Journal of Medical Economics

IF3
论文数387
被引数3584
期刊论文 387
发表时间
delete
Uncovering the full economic impact of biosimilars: a “would have spent” counterfactual analysis of five reference biologics (infliximab, adalimumab, bevacizumab, rituximab, and trastuzumab) in the United States and Europe, 2016–2025揭示生物类似药的全部经济影响：对五种参考生物制剂（英夫利昔单抗、阿达木单抗、贝伐珠单抗、利妥昔单抗和曲妥珠单抗）在美国和欧洲2016–2025年的“本应支出”反事实分析
deleteJournal of Medical Economics
IF3
delete2026-10-28
delete0
deleteOAAI
deleteSeungjae Yi; Minyoung Jang; Federico Di Biasio; Dongkyu Kim; Taek Sang Kwon; Jooyeop Lee; Jihyun Lee; Anja Tuomioja-Busk; Nicolas Van Gelder
delete分享
delete收藏
Evaluating the cost-effectiveness of enhanced cardiovascular-renal-metabolic (CVRM) screening in UK, France, Germany and Australia: a microsimulation-based enhanced CVRM screening analysis评估英国、法国、德国和澳大利亚增强型心血管-肾脏-代谢（CVRM）筛查的成本效益：基于微模拟的增强型CVRM筛查分析
deleteJournal of Medical Economics
IF3
delete2026-10-27
delete0
deleteOAAI
deleteFiona Adshead; Georgios Xydopoulos; Vasileios Vasilopoulos; Alexandre Babin; Amitava Banerjee; Bruno Detournay; Jamie Espín; Ines Hassan; Matt Kearney; Jan T. Kielstein; Koichiro Kuwahara; Nirosha Lederer; Carel W. le Roux; Natalie Raffoul; Lise Retat; Scott B. Robinson; Andrew Sindone; Juergen Wasem; Clélia-Elsa Froguel
delete分享
delete收藏
Real-world utilization of gonadotropins and the associated cumulative live birth rates in the United States: a retrospective claims database analysis美国促性腺激素的实际应用及其相关的累积活产率：一项回顾性理赔数据库分析
deleteJournal of Medical Economics
IF3
delete2026-10-21
delete0
deleteOAAI
deleteWeiguang Xue; Emily Jungheim; Min Yang; Sanghyuk Seo; Lindsay Kelly; Wei Zhou
delete分享
delete收藏
Healthcare utilization and costs associated with dextromethorphan-bupropion versus selected other branded treatments for major depressive disorder: a US real-world study重度抑郁症患者使用右美沙芬-安非他酮与特定其他品牌治疗方案相关的医疗资源利用和成本：一项美国真实世界研究
deleteJournal of Medical Economics
IF3
delete2026-10-21
delete0
deleteOAAI
deleteLeslie Citrome; Yang Zhao; Courtney Zeni; Nicole Princic; Megan Richards; Shawn P. Alter; Andrew J. Cutler
delete分享
delete收藏
Androgen receptor inhibitor double therapies in the management of metastatic castration-sensitive prostate cancer: a cost-effectiveness analysis雄激素受体抑制剂双重疗法在管理转移性去势敏感性前列腺癌中的应用：一项成本效益分析
deleteJournal of Medical Economics
IF3
delete2026-10-07
delete0
deleteOAAI
deleteWilliam V. Padula; Benjamin G. Cohen; Paul Steel; Sreevalsa Appukkuttan; Bashir Kalayeh; Matthew Rettig
delete分享
delete收藏
Cost-effectiveness of etranacogene dezaparvovec compared to eftrenonacog alfa for the treatment of adult patients with severe and moderately severe haemophilia B in Sweden与eftrenonacog alfa相比，etranacogene dezaparvovec在瑞典治疗成年中重度血友病B患者中的成本效益分析
deleteJournal of Medical Economics
IF3
delete2026-10-04
delete0
deleteOAAI
deleteSongkai Yan; Olof Mogard; Anna Tjärnlund-Wolf; Fredrik Sjöö; André Eid; Jack Ettinger; Douglass Drelich; Radovan Tomic; Stina Johansson
delete分享
delete收藏
Real-world treatment patterns, healthcare resource utilization, and costs associated with high-risk endometrial cancer in England: a retrospective cohort study英格兰高危子宫内膜癌的真实世界治疗模式、医疗资源利用及成本：一项回顾性队列研究
deleteJournal of Medical Economics
IF3
delete2026-10-01
delete0
deleteOAAI
deleteEleanor Ralphs; Vimalanand S. Prabhu; Erik Landfeldt; Jess Ridsdale-Smith; Cheryl Teoh; Karen Macey; Nikolay Trankov; Alexandrina Lambova; Jasmine Lichfield; Gemma Eminowicz
delete分享
delete收藏
Cost-effectiveness of Orca-T vs allo-HCT with conventional GVHD prophylaxis for the treatment of advanced hematologic malignancies in the United States奥拉帕尼联合阿西替尼（Orca-T）与常规GVHD预防的allo-HCT在美国治疗晚期血液恶性肿瘤的成本效益比较
deleteJournal of Medical Economics
IF3
delete2026-09-29
delete0
deleteOAAI
deleteRawan Faramand; James Scott McClellan; Anna Pavlova; Rocio Manghani; Andrea Blank; Matia Saeedian; Shivani Yadav; Miguel-Angel Perales
delete分享
delete收藏
Assessing the consistency of overall survival extrapolations in Swedish health technology assessment reports of oncology treatments using extended follow-up data评估瑞典卫生技术评估报告中肿瘤治疗总体生存期外推的一致性：使用扩展随访数据
deleteJournal of Medical Economics
IF3
delete2026-09-26
delete0
deleteOAAI
deleteMáté Szilcz; Olof Mogard; Mattias Ekman; Olof Lindgren; Fredrik Nilsson; Kasper Johannesen; Emma Medin
delete分享
delete收藏
Cost comparison of intravenous immunoglobulin and subcutaneous efgartigimod in patients with chronic inflammatory demyelinating polyneuropathy静脉注射免疫球蛋白与皮下注射efgartigimod在慢性炎症性脱髓鞘多发性神经病患者的成本比较
deleteJournal of Medical Economics
IF3
delete2026-09-21
delete0
deleteOAAI
deleteSuraj A. Muley; Irene Gucciardi; Vivek Kaisare; Christoph Wissmann; Sarah Bandy; Wei-Shi Yeh; Leslie Myers
delete分享
delete收藏
Clinical and economic value of onabotulinumtoxinA vs oral pharmacotherapies in overactive bladder in the United States在美国，奥 nabotulinumtoxinA 相较于口服药物治疗过度活动性膀胱的临床和经济价值
deleteJournal of Medical Economics
IF3
delete2026-09-21
delete0
deleteOAAI
deleteDoreen E. Chung; Benjamin M. Brucker; Stephen Chaplin; Qianyi Li; Ritu Singh; Erika Wissinger; Annaliza Dominguez
delete分享
delete收藏
Incidence of comorbidities, healthcare resource utilization and costs among people with HIVHIV感染者中合并症的发生率、医疗资源利用及成本
deleteJournal of Medical Economics
IF3
delete2026-09-21
delete0
deleteOAAI
deleteJoshua P. Cohen; Mary J. Christoph; Vamshi Ruthwik Anupindi; Nazneen Fatima Shaikh; JeanPierre Coaquira; Uche Mordi; Kristen Haloski; Alice Hsiao; Aimee M. Near
delete分享
delete收藏
Retrospective database analysis of annual direct costs and complications for patients with type 1 diabetes and hypoglycemia in the US对美国1型糖尿病合并低血糖患者年度直接费用及并发症的回顾性数据库分析
deleteJournal of Medical Economics
IF3
delete2026-09-11
delete0
deleteOAAI
deleteAdriana Boateng-Kuffour; Nanxin Li; Vamshi Ruthwik Anupindi; Keval Chandarana; Liang Chen; Michael Hull; Xiaoyu Zhou; Jason L. Gaglia; Mitch Dekoven; Beth Barber
delete分享
delete收藏
Projected burden of bloodstream infections and the impact of molecular rapid diagnostic testing on costs and mortality in England and the United States (2025–2029): a population-level budget impact analysis英格兰和美国2025–2029年血流感染负担预测及分子快速诊断检测对成本和死亡率的影响：一项基于人群水平的预算影响分析
deleteJournal of Medical Economics
IF3
delete2026-09-10
delete0
deleteOAAI
deleteJames K. Karichu; Mark Pennington; Kiera Lander; Tiffeny T. Smith; Adam Thornberg
delete分享
delete收藏
Cost-effectiveness analysis of pneumococcal vaccination of at-risk and high-risk adults aged 18–64 years in Switzerland using PCV21使用PCV21对瑞士18-64岁成人高风险和极高风险人群进行肺炎球菌疫苗接种的成本效益分析
deleteJournal of Medical Economics
IF3
delete2026-09-10
delete0
deleteOAAI
deleteMuloongo Simuzingili; Zinan Yi; Andrea Favre-Bulle; Thomas Mutschler; Eleana Tsoumani; Kwame Owusu-Edusei
delete分享
delete收藏
Societal and fiscal gains from HPV vaccination in Poland – return on investment from extending access to HPV vaccination波兰HPV疫苗接种的社会和财政收益——扩大HPV疫苗接种覆盖面的投资回报
deleteJournal of Medical Economics
IF3
delete2026-09-09
delete0
deleteOAAI
deleteRafal Jaworski; Nikolaos Kotsopoulos; Marcin Czech; Mark P. Connolly; Andrew Pavelyev; Alicja Wojcik; Ugne Sabale
delete分享
delete收藏
Cost-effectiveness analysis of elranatamab versus physician’s choice of treatment (non–BCMA-directed regimens) in patients with triple class exposed multiple myeloma in Japan在日本三药难治性多发性骨髓瘤患者中，elranatamab相较于医师选择治疗方案（非BCMA靶向方案）的成本效益分析
deleteJournal of Medical Economics
IF3
delete2026-09-08
delete0
deleteOAAI
deleteAkira Yuasa; Mitsuhiro Nagano; Yoichi Kamei; Kengo Hatsuyama; Hiroyuki Matsuda; Patrick Hlavacek; Marco DiBonaventura; Kenshi Suzuki
delete分享
delete收藏
Cost-effectiveness analysis of Cardioform vs. Amplatzer: concerns regarding methodological transparency and interpretation of clinical resultsCardioform与Amplatzer的成本效益分析：关于方法学透明度和临床结果解释的担忧
deleteJournal of Medical Economics
IF3
delete2026-09-03
delete0
deleteOAAI
deleteDavid W. Hutton; Anne M. Ryschon; Scott Goates; Jan B. Pietzsch; Lars Søndergaard
delete分享
delete收藏
Real-world healthcare resource utilization and cost burden of COVID-19 in commercially insured adults at high-risk of severe disease in the US: a retrospective database analysis美国商业保险覆盖的高危成人中COVID-19的现实世界医疗资源利用和成本负担：一项回顾性数据库分析
deleteJournal of Medical Economics
IF3
delete2026-09-03
delete0
deleteOAAI
deleteTendai Mugwagwa; Benjamin A. Abramoff; Siddharth Karanth; Tram Nham; Ravi K. Goyal; Elizabeth Esterberg; Gurinder S. Sidhu; Alon Yehoshua; Ruth Mokgokong
delete分享
delete收藏
Response to Hutton et al. letter to the editor对Hutton等人致编辑的信的回应
deleteJournal of Medical Economics
IF3
delete2026-09-02
delete0
deleteOAAI
deleteJohn J. Volpi; Lambertus F. Wolters; Timon Louwsma; Mitesh Nakum; Ryan J. Imhoff; Erik J. Landaas
delete分享
delete收藏